Results 211 to 220 of about 48,916 (224)
Some of the next articles are maybe not open access.

Bevacizumab Impairs Morphine Analgesia through Tuberous Sclerosis Complex 1–Mechanistic Target of Rapamycin-Autophagy Dysregulation

Background: Bevacizumab is a widely used anti-VEGF-A therapy in oncology and ophthalmology, valued for its potent anti-angiogenic effects across cancer and ocular diseases. Beyond angiogenesis, growing evidence suggests that VEGF-A also contributes to neuronal homeostasis, including autophagy regulation, synaptic plasticity, and nociceptive ...
Cheng Li, Zhiwei Xu, Quan Ma, See PDF
openaire   +1 more source

Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex

Pediatric Neurology, 2020
David Neal Franz   +2 more
exaly  

Mechanistic Target of Rapamycin Complex 1 (mTORC1) Activity in an In Vitro Model of AKI

Journal of the American Society of Nephrology
Asha Rath, Sian E. Piret
openaire   +1 more source

Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids

Journal of Hepatology, 2017
T. Moustafa   +5 more
openaire   +1 more source

American Journal of Respiratory and Critical Care Medicine

American Journal of Respiratory and Critical Care Medicine, 2016
Steven Bozinovski   +2 more
exaly  

Environmental signaling through the mechanistic target of rapamycin complex 1

Cell Cycle, 2014
Hongfeng Chen   +2 more
exaly  

Home - About - Disclaimer - Privacy